Treatment Adherence clinical trials at UCSF
1 research study open to eligible people
Strategies for Improving Linkage-to-Care After Eye Disease Screening
open to eligible people ages 60 years and up
The goal of this randomized, parallel-group, controlled trial is to compare methods of improving linkage-to-care for participants in the Village Integrated Eye Worker II (VIEW II) trial who are referred to the eye hospital following eye disease screening. Participants who are referred to the hospital at an eye screening visit will be randomized to three different linkage-to-care interventions: (1) text message reminders, (2) reminders from health workers, or (3) no intervention. The primary outcome of the trial will be whether or not the participant presented to the eye hospital for a referral visit by 21 days following screening.
San Francisco, California
Our lead scientists for Treatment Adherence research studies include Jeremy Keenan, MD, MPH.